Merck stock pops on Deutsche Bank upgrade — what to watch ahead of ASCO GU
Merck & Co climbed 1.8% to $121.41 in Friday’s after-hours session, boosted by a Deutsche Bank upgrade to buy and a raised price target. Analyst James Shin argued, “We believe the market is currently undervaluing MRK … a clear path for MRK to navigate this transition.” Deutsche Bank projects that between the pipeline and recent acquisitions, Merck could tack on over $35 billion in risk-adjusted revenue by 2035.